Experts Discuss Clinical Application of TRK Inhibitors and Tumor Agnostic NTRK Fusion Testing

Download All
In this online educational program, learn how to optimize oncology patient care by leveraging tumor-agnostic NTRK fusion testing and TRK inhibitors. Review expert insights on the latest data with an on-demand Webcast and downloadable slides from the live CCO symposium in Chicago.
Todd M. Bauer, MD
Marcia Brose, MD, PhD
George D. Demetri, MD

On-Demand Webcast

Watch this on-demand Webcast from our live symposium to review the latest clinical data and expert perspectives on targeting TRK in solid tumors, available and emerging TRK inhibitors, and implementing NTRK fusion testing in practice.

Todd M. Bauer, MD Marcia Brose, MD, PhD George D. Demetri, MD Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: July 15, 2019 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Bayer HealthCare Pharmaceuticals Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings